Patent Assignment
Reel/Frame 031428/0744
Assignment of Assignor's Interest
Recorded: 2013-10-17
Pages: 3
Assignor
TARGANTA THERAPEUTICS CORP.
Executed: 2013-10-17
Assignee
THE MEDICINES COMPANY
8 SYLVAN WAY, PARSIPPANY, NEW JERSEY, 07054
Covered Property
(1)
Use of Oritavancin for Prevention and Treatment of Anthrax
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Jan 8, 2018
From: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; CEM-102 PHARMACEUTICALS, INC.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 045019/0552 →
Assignment of Assignor's Interest
Feb 21, 2019
From: THE MEDICINES COMPANY
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 048407/0911 →
Amended and Restated Intellectual Property Security Agreement
Aug 25, 2022
From: MELINTA THERAPEUTICS, LLC
To: SILICON VALLEY BANK
Reel/Frame 061314/0459 →
Termination and Release of Intellectual Property Security Agreement (Patents) at Reel 054836 and Frame 0765 and Reel 061314 and 0459
Aug 29, 2025
From: SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY
To: MELINTA THERAPEUTICS, LLC
Reel/Frame 072772/0097 →